Loading
Loading…
Loading…
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Fee/PreQual/Technical | Admitted-Fee/PreQual/Technical |
| 2 | Admitted-Fee/PreQual/Technical | Admitted-Fee/PreQual/Technical |
| 3 | Admitted-Fee/PreQual/Technical | Admitted-Fee/PreQual/Technical |
Tender Value
Refer Docs
EMD Value
₹30,000
Closing Date
19 Aug 2026, 9:00 amClosed
MS, MGH
M. S. office, Mata Gujri Hospital, Tilak Nagar, New Delhi
Supply of Injection Paracetamol 1000 mg/100 mL (Paracetamol for Intravenous Infusion) at Mata Gujri Hospital, Tilak Nagar under the jurisdiction of Municipal Corporation of Delhi
2026_MCD_287338_1
44/MS/MGH/MCD/2026
Open Tender
Drugs and Pharmaceutical Products
Supply
45 days
M. S. office, Mata Gujri Hospital, Tilak Nagar
Please refer Tender documents.
2 documents required · 2 mandatory
₹590
₹30,000
20 Aug 2026
12 Aug 2026
20 Aug 2026
12 Aug 2026
19 Aug 2026
12 Aug 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Supply of Injection Paracetamol 1000 mg/100 mL (Paracetamol for Intravenous Infusion) at Mata Gujri Hospital, Tilak Nagar under the jurisdiction of Municipal Corporation of Delhi | |||||
| 1.01 | Supply of Injection Paracetamol 1000 mg/100 mL (Paracetamol for Intravenous Infusion) at Mata Gujri Hospital, Tilak Nagar under the jurisdiction of Municipal Corporation of Delhi | - | Bottles | 52.5 | - |
stage.html
html • 0.02 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.89 MB
NIT44.pdf
Tender Documents • 0.87 MB
BOQ_335270.xls
BOQ • 0.31 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .